Cervical nitric oxide release and persistence of high-risk human papillomavirus in women

International Journal of Cancer

Volumn 128, Issue 12, 2011, Pages 2933-2937

  Rahkola, Päivi ^a   Väisänen Tommiska, Mervi ^a   Tuomikoski, Pauliina ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

cervix; cytology; papillomavirus; progression; regression

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; METABOLITE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX MUCUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CERVIX UTERI; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; YOUNG ADULT;

EID: 79955372810     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25637     Document Type: Article

References (33)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV,. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65. (Pubitemid 34293391)
2. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K,. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health study. J Infect Dis 2002; 186: 462-9. (Pubitemid 34876254)
3. Stanley M,. Immune responses to human papillomavirus. Vaccine 2006; 24 (suppl 1): S16-22.
4. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS,. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 123-37. (Pubitemid 351951589)
5. zur Hausen H,. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009; 384: 260-5.
6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27. (Pubitemid 36159887)
7. Kim YT, Lee JM, Hur SY, Cho CH, Kim YT, Kim SC, Kang SB,. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer 2010; 126: 1903-9.
8. Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM,. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2007; 109: 309-13. (Pubitemid 46197421)
9. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E,. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337: 1284-95.
10. Coleman JW,. Nitric oxide in immunity and inflammation. Int Immunopharmacol 2001; 1: 1397-406. (Pubitemid 32622786)
11. Bogdan C, Rollinghoff M, Diefenbach A,. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12: 64-76. (Pubitemid 30093452)
12. Fukumura D, Kashiwagi S, Jain RK,. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006; 6: 521-34. (Pubitemid 43980541)
13. Hiraku Y, Tabata T, Ma N, Murata M, Ding X, Kawanishi S,. Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Sci 2007; 98: 964-72. (Pubitemid 46865378)
14. Wei L, Gravitt PE, Song H, Maldonado AM, Ozbun MA,. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res 2009; 69: 4878-84.
15. Tornblom SA, Maul H, Klimaviciute A, Garfield RE, Bystrom B, Malmstrom A, Ekman-Ordeberg G,. mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod Biol Endocrinol 2005; 3: 33-41.
16. Vaisanen-Tommiska M, Nuutila M, Aittomaki K, Hiilesmaa V, Ylikorkala O,. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening. Am J Obstet Gynecol 2003; 188: 779-85. (Pubitemid 36332451)
17. De Andrea M, Mondini M, Azzimonti B, Dell'oste V, Germano S, Gaudino G, Musso T, Landolfo S, Gariglio M,. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res 2007; 124: 220-5. (Pubitemid 46216554)
18. Mazibrada J, Ritta M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, Ciotti M, Orlando A, Surico N, Chiusa L, Landolfo S, Gariglio M,. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 2008; 108: 112-20. (Pubitemid 350299432)
19. Rahkola P, Mikkola TS, Ylikorkala O, Vaisanen-Tommiska M,. Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix. Gynecol Oncol 2009; 114: 323-6.
20. Smith JH,. Bethesda 2001. Cytopathology 2002; 13: 4-10. (Pubitemid 34415652)
21. Bosch FX, de Sanjose S,. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23: 213-27. (Pubitemid 47015785)
22. Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M,. Comparison of the digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 2006; 44: 2141-6. (Pubitemid 43902166)
23. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, Rohan TE,. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180: 1415-23. (Pubitemid 29506440)
24. Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL,. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008; 197: 1436-47. (Pubitemid 351706468)
25. Nam K, Chung S, Kim J, Jeon S, Bae D,. Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 2009; 20: 91-5.
26. Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis 2009; 199: 936-44.
27. zur Hausen H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50. (Pubitemid 37328947)
28. Kruse AJ, Baak JP, Janssen EA, Kjellevold KH, Fiane B, Lovslett K, Bergh J, Robboy S,. Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. Cell Oncol 2004; 26: 13-20. (Pubitemid 39108239)
29. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I,. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol 2006; 59: 1017-28. (Pubitemid 44570323)
30. Hariri J, Oster A,. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol 2007; 26: 223-8. (Pubitemid 46986053)
31. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V, Paraskevaidis E,. p16(INK4A) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-20.
32. Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ,. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 2007; 121: 1749-55. (Pubitemid 47417293)
33. Woo YL, van den Hende M, Sterling JC, Coleman N, Crawford RA, Kwappenberg KM, Stanley MA, van der Burg SH,. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer 2010; 126: 133-41.